French pharmaceutical company said drug could treat COVID-19 patients after promising test results
A leading French pharmaceutical company said it could potentially treat 300,000 COVID-19 patients with the anti-malarial drug Plaquenil after what it described as “promising” test results.
Sanofi said it was ready to offer France millions of doses of Plaquenil, a spokesperson for the laboratory told AFP, adding that the group was ready to work with French health authorities “to confirm these results.”
The study on 24 patients with coronavirus using Plaquenil, a hydroxychloroquine molecule, which has also been used for decades for the treatment of autoimmune diseases like lupus or rheumatoid arthritis.
Six days after the start of taking Plaquenil, the virus had disappeared in three-quarters of those treated, said Professor Didier Raoult, who is director of the Institut Hospitalo-Universitaire de Marseille.
The French government said the clinical trials were “promising” and would be extended to more patients.
You may be interested
Coronavirus Greece: 842 new cases, 427 in Atticamakis - Jan 26, 2021
The Greek authorities announced today 842 new cases of the new coronavirus, of which 13 were identified after checks at…
No side effects from vaccinations recorded in Greece, says Head of National Vaccination CommitteePanos - Jan 26, 2021
No adverse side effects have been recorded so far during the vaccination of the country's elderly citizens, said the Head…
Elon Musk launches 143 small satellites in space at the same time – New recordPanos - Jan 26, 2021
Elon Musk’s SpaceX launched 143 small satellites simultaneously on Sunday, a new world record. The launch was carried out with…